文献速递肝病消化道肿瘤与早癌消化内镜

肝切除术治愈肝细胞癌的概率评估

The chances of hepatic resection curing hepatocellular carcinoma.
PubMed 文献 · J Hepatol · 2019-11-30

该研究基于2523例接受肝切除术的肝细胞癌患者数据,拟合统计治愈模型,比较术后无病生存与慢性肝炎和/或肝硬化患者及一般人群的预期生存。结果显示,切除术使患者达到与慢性肝病者相同预期寿命的概率为26.3%,与一般人群相同的概率为17.1%,治愈概率随时间推移而增加。

要点

  • 肝切除术可使部分肝细胞癌患者达到统计治愈,与慢性肝病者相同预期寿命的概率为26.3%。
  • 以一般人群为参照,治愈比例降至17.1%,未治愈患者中位无病生存期为1.5年。
  • 年龄和早期复发风险(2年内)是治愈机会的独立决定因素,低危者治愈概率36.0%,高危者约3.6%。

核心结论

  • 肝切除术可使肝细胞癌患者达到统计治愈,治愈可能性随无复发生存时间延长而增加。

研究设计与样本

  • 研究纳入2523例接受肝切除术的肝细胞癌患者,拟合统计治愈模型,按性别、年龄、种族/民族和诊断年份匹配,比较术后无病生存与慢性肝炎和/或肝硬化患者及一般人群的预期生存。

主要发现

  • 切除术使患者达到与慢性肝炎和/或肝硬化者相同预期寿命的概率为26.3%。
  • 达到该结果的条件概率具有时间依赖性,需约8.9年才能以95%的确定性实现。
  • 以一般人群为参照时,治愈比例降至17.1%。
  • 未治愈患者的中位无病生存期为1.5年。
  • 多变量分析中,患者年龄和早期复发风险(2年内)是治愈机会的独立决定因素(p <0.001),治愈概率从低危者的36.0%到高危者的约3.6%不等。

临床怎么用

  • 研究数据可用于临床决策,并向患者提供关于肝切除术治愈可能性的准确信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The popular sense of the word "cure" implies that a patient treated for a specific disease will return to have the same life expectancy as if he/she had never had the disease. In analytic terms, it translates into the concept of statistical cure which occurs when a group of patients returns to having similar mortality to a reference population. The aim of this study was to assess the probability of being cured from hepatocellular carcinoma (HCC) by hepatic resection. METHODS: Data from 2,523 patients undergoing resection for HCC were used to fit statistical cure models, to compare disease-free survival (DFS) after surgery to the survival expected for patients with chronic hepatitis and/or cirrhosis and the general population, matched by sex, age, race/ethnicity and year of diagnosis. RESULTS: The probability of resection enabling patients with HCC to achieve the same life expectancy as those with chronic hepatitis and/or cirrhosis was 26.3%. The conditional probability of achieving this result was time-dependent, requiring about 8.9 years to be accomplished with 95% certainty. Considering the general population as a reference, the cure fraction decreased to 17.1%. Uncured patients had a median DFS of 1.5 years. In multivariable analysis, patient's age and the risk of early HCC recurrence (within 2 years) were independent determinants of the chance of cure (p <0.001). The chances of being cured ranged between 36.0% for individuals at low risk of early recurrence to approximately 3.6% for those at high risk. CONCLUSION: Estimates of the chance of being cured of HCC by resection showed that cure is achievable, and its likelihood increases with the passing of recurrence-free time. The data presented herein can be used to inform decision making and to provide patients with accurate information. LAY SUMMARY: Data from 2,523 patients who underwent resection for hepatocellular carcinoma were used to estimate the probability that resection would enable treated patients to achieve the same life expectancy as patients with chronic hepatitis and/or cirrhosis, and the general population. Herein, the cure model suggests that in patients with hepatocellular carcinoma, resection can enable patients to achieve the same life expectancy as those with chronic liver disease in 26.3% of cases and as the general population in 17.1% of cases.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Cucchetti A, Zhong J, Berhane S, et al. The chances of hepatic resection curing hepatocellular carcinoma. J Hepatol. 2019. PMID: 31790765. doi:10.1016/j.jhep.2019.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。